NCT06377124Recruiting
A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients
A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Patients With Lung Cancer - A Pragmatic Randomized Controlled Trial With Mixed-method Evaluation
Source: ClinicalTrials.gov · Last updated 19 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Lung cancers patients often experience multiple symptoms (e.g. fatigue, dyspnea, distress, depression, sleep disturbance). The current study attempts to explore the efficacy of the Smart Self-Management Support Programme (3S) in improving quality of life of patients using self-management support programme with mobile devices.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 320 (estimated)
- First submitted
- 9 Apr 2024
- Start date
- 22 Apr 2024
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- The University of Hong Kong
- Diseases
- Lung cancer
- NCT number
- NCT06377124
What you commit to
- Study type: Interventional
- Planned participants: 320
- From 22 Apr 2024 to the primary completion date, 31 Mar 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously untreated symptomatic brain metastases
Other illness
- Serious active infection
- Severe respiratory insufficiency
- Diagnosed psychiatric illness with or without medication
- Family Caregivers:
Other
- Preparing for lung operation
- Skeletal fragility
- Inability to walk
- Uncontrolled pain
- Unable to speak and read Chinese
- Unwilling to complete the patient-reported outcome questionnaire
Who the study is looking for
- Aged 18 years or above
- Diagnosis of advanced-stage (stage III or stage IV) non-small cell lung cancer
- Ambulatory and capable of all self-care activities (ECOG ≤2)
- Either undergoing or has finished oncology therapy
- Mentally, cognitively and physically fit to join as determined by the doctor in charge and responsible clinical investigators
- Can speak and read Chinese
- Willing to complete the patient-reported outcome questionnaire
- Has a smartphone with WhatsApp or WeChat
- Aged 18 years or above
- Family caregivers of recruited patients
Criteria the registry did not label
- Patients:
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Queen Mary Hospital Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Not yet recruiting |
| Queen Elizabeth Hospital Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Recruiting |
| United Christian Hospital Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.